NOVEL ANKYRIN REPEAT BINDING PROTEINS AND THEIR USES

The present invention relates to recombinant binding proteins comprising one or more designed ankyrin repeat domains with binding specificity for coronavirus spike proteins, nucleic acids encoding such proteins, pharmaceutical compositions comprising such proteins or nucleic acids, and the use of su...

Full description

Saved in:
Bibliographic Details
Main Authors WALSER, Marcel, AMSTUTZ, Patrick, CALABRO, Valerie, Perrine
Format Patent
LanguageEnglish
Spanish
Published 19.01.2023
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to recombinant binding proteins comprising one or more designed ankyrin repeat domains with binding specificity for coronavirus spike proteins, nucleic acids encoding such proteins, pharmaceutical compositions comprising such proteins or nucleic acids, and the use of such proteins, nucleic acids or pharmaceutical compositions in the treatment of coronavirus diseases, particularly diseases caused by SARS-CoV-2. La presente invención se refiere a proteínas de unión recombinantes que comprenden uno o más dominios de repetición de anquirina diseñados con especificidad de unión para proteínas de espiga de coronavirus, ácidos nucleicos que codifican dichas proteínas, composiciones farmacéuticas que comprenden dichas proteínas o ácidos nucleicos, y el uso de dichas proteínas, ácidos nucleicos o composiciones farmacéuticas en el tratamiento de enfermedades por coronavirus, particularmente enfermedades causadas por el SARS-CoV-2.
Bibliography:Application Number: CR20220000618